StockStory.org on MSN

CME Q4 deep dive: Retail and crypto expansion fuel stable results, new products ahead

Financial derivatives exchange CME Group (NASDAQ:CME) in Q4 CY2025, with sales up 8.1% year on year to $1.65 billion. Its non-GAAP profit of $2.77 per share was 1% above analysts’ consensus estimates.
Zacks Investment Research on MSN

CME Group (CME) Q4 earnings and revenues top estimates

CME Group (CME) came out with quarterly earnings of $2.77 per share, beating the Zacks Consensus Estimate of $2.75 per share.

CME Group Inc. (CME) Q4 2025 Earnings Call Transcript

Q4 2025 Earnings Call February 4, 2026 8:30 AM ESTCompany ParticipantsAdam Minick - Investor ContactTerrence Duffy - Chairman ...
Tokenist

Earnings Recap: Boston Scientific, CME, and Johnson Controls Deliver Quarterly Beats

BSX, CME, and JCI have all reported strong earnings, surpassing expectations and demonstrating robust growth and resilience in their respective sectors.